期刊文献+

miRNA-135b靶向作用于APC对三阴型乳腺癌细胞增殖、侵袭及迁移的影响 被引量:12

Effect of miRNA-135b on proliferation, invasion and migration of triple-negative breast cancer by targeting APC
原文传递
导出
摘要 目的 探讨miRNA-135b在多种乳腺癌细胞系中表达及靶向APC基因对三阴型乳腺癌细胞增殖、侵袭及迁移能力的影响.方法 通过实时荧光定量(RT)-聚合酶链反应(PCR)检测miRNA-135b在正常乳腺细胞系Hs578Bst及乳腺癌细胞系Hs578T、MCF7、HCC1937、MDA-MB-231、MDA-MB-453、BT-549和MDA-MB-468中的表达,选取其中两种高表达miRNA-135b的MDA-MB-231、MDA-MB-468为对象,根据处理方法,实验分3组:空白组(自然生长细胞)、阴性对照组(转染阴性对照试剂)、实验组(转染miRNA-135b抑制剂).采用RT-PCR及Western印迹检测APC基因的表达;Cell Counting Kit-8 (CCK-8)实验、Transwell体外侵袭实验检测乳腺癌细胞增殖、侵袭及迁移能力.结果 miRNA-135b在三阴型乳腺癌细胞系中的表达量均高,其中在MDA-MB-231细胞中阴性对照组和实验组分别0.97 ±0.13、0.42 ±0.03;MDA-MB-468细胞转染miRNA-135b抑制剂后,1.02±0.03、0.47±0.04;实验组中miRNA-135b的表达受到显著抑制,差异有统计学意义.实验组APC基因mRNA及其蛋白的表达显著上调,MDA-MB-231中阴性对照组和实验组分别为1.01±0.11、1.75±0.13(P=0.013,P=0.021),MDA-MB-468中(P=0.017,P=0.014);实验组细胞增殖活性明显受到抑制MDA-MB-231中(P=0.00),MDA-MB-468中(P=0.01);侵袭及迁移能力明显降低MDA-MB-231中(P=0.002,P=0.00),MDA-MB-468中(P=0.01,P=0.00).结论 miRNA-135b在多种三阴型乳腺癌细胞中呈高表达,可靶向抑制APC基因,促进三阴型乳腺癌细胞系MDA-MB-231及MDA-MB-468的增殖、侵袭及迁移. Objective To explore the expression of miRNA-135b in a variety of breast cancer cell lines and its function on the proliferation,invasion and migration in triple-negative breast cancer cell lines by targeting adenomatous polyposis coli (APC).Methods Quantitative real-time (RT)-PCR was used to detect the expression of miRNA-135b in seven breast cancer cell lines and one normal breast cell line.The three-negative breast cancer cell lines MDA-MB-23 1 and MDA-MB-468 with miRNA-135b high-expression were divided into three groups:the normal growth group,the negative control group (transfected with negative counter-part) and the experimental group (transfected with miRNA-135b inhibitors).RT-PCR and Western blot were used to explore the expression of APC.The proliferation was detected by Cell Counting Kit-8 (CCK-8) method and the invasion and migration were detected by Transwell method.Results The levels of miRNA-135b were higher in triple-negative breast cancer cell lines than other types,especially MDA-MB-231 (P =0.001) and MDA-MB-468 (P =0.036).Compared with normal growth group and negative control group,the mRNA and protein of APC were up-regulated in experimental group MDA-MB-231(P =0.013,P =0.021),MDA-MB-468 (P =0.017,P =0.014).CCK-8 results showed that the proliferation rate of experimental group was decreased compared with negative control and nornal growth group MDA-MB-231 (P =0.00),MDA-MB-468 (P =0.01).The invasion and migration ability of MDAMB-231 (P =0.002,P =0.00) and MDA-MB-468 (P =0.01,P =0.00) were obviously decreased after transfected miRNA-135b inhibitors.Conehsion The expressions of miRNA-135b were higher in most triple-negative breast cancer cell lines than others,miRNA-135b could promote the proliferation,invasion and migration in triple-negative breast cancer cell lines MDA-MB-231 and MDA-MB-468,and APC was one of the target genes of miRNA-135b by participating in the process of regulation.
出处 《中华医学杂志》 CAS CSCD 北大核心 2015年第30期2474-2477,共4页 National Medical Journal of China
基金 国家自然科学基金(81302290) 山东省自然科学基金(ZR2013HM019)
关键词 乳腺肿瘤 miRNA-135b APC CCK-8试验 Transwell试验 wBreast neoplasm miRNA-135b Genes, APC CCK-8 assay Transwell assay
  • 相关文献

参考文献9

  • 1Svedlund J, Auren M, Sundstrom M, et al. Aberrant WNT/[3- catenin signaling in parathyroid carcinoma [J]. Mol Cancer, 2010,15(9): 294.
  • 2Arigoni M, Barutello G, Riccardo F, et al. miR-135b Coordinates Progression of ErhB2-Driven Mammary Carcinomas through Suppression of MIDI and MTCH2 [J]. Am J Pathology, 2013, 182 (6) : 2058-2070.
  • 3Kwak PB, Iwasaki S, Tomari Y. The microRNA pathway and cancer [J]. Cancer Science, 2010, 10 I : 2309 -2315.
  • 4Clevers H, Nusse R. Wntl[3-catenin signaling and disease [J] . Cell, 2012, 149( 6) : 1192-1205.
  • 5Nagel R, le Sage C, Diosdado B, et al. Regulation of the adenomatous polyposis coli gene by the miR-135b family in colorectal cancer [J]. Cancer Res, 2008, 68 ( 14 ) : 5795 -5802.
  • 6Brocardo M, Henderson BR. APC shuttling to the membrane, nucleus and beyond [J]. Trends Cell Bioi, 2008, 18 ( 12) :587- 596.
  • 7Bienz M, Hamada F. Adenomatous polyposis eoli proteins and cell adhesion [J]. Current Opinion Cell BioI, 2004,16(7): 528-535.
  • 8Aoki K, Taketo MM. Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene [J]. J Cell Sci, 2007, 120( 19) : 3327-3335.
  • 9王霖沛,马筱秋,蔡建春.微小RNA-135b在胃癌发生发展中的临床病理意义及其作用[J].中华医学杂志,2012,92(46):3269-3273. 被引量:10

二级参考文献15

  • 1Bartel DP. MicroRNAs : target recognition and regulatory functions. Cell, 2009, 136: 215-233.
  • 2Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 2005, 120 : 15-20.
  • 3Duan R, Pak C, Jin P. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet, 2007, 16:1124-1131.
  • 4Lulla RR, Costa FF, Bischof JM, et al. Identification of differentially expressed microRNAs in Osteosarcoma. Sarcoma, 2011:732690.
  • 5Sarver AL, French A J, Borralho PM, et al. Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer, 2009, 9:401.
  • 6Tong AW, Fulgham P, Jay C, et al. MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther, 2009, 16:206-216.
  • 7Yu F, Yao H, Zhu P, et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell, 2007, 131 : 1109-1123.
  • 8Steinemann D, Tauscher M, Praulich I, et al. Mutations in the let-7 binding site-a mechanism of RAS activation in juvenile myelomonocytic leukemia?. Haematologica, 2010, 95:1616.
  • 9Wong TS, Man OY, Tsang CM, et al. MicroRNA let-7 suppresses nasopharyngeal carcinoma ceils proliferation through downregulating c-Myc expression. J Cancer Res Clin Oncol, 2011,137: 415-422.
  • 10Meng F, Henson R, Lang M, et al. Involvement of human micro- RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology, 2006, 130: 2113- 2129.

共引文献9

同被引文献113

  • 1徐江锋,罗庚求.上皮细胞间质转型与肿瘤转移[J].国际病理科学与临床杂志,2007,27(5):393-396. 被引量:17
  • 2Farazi T A, Spitzer J I, Momzov P, et al. miRNAs in human cancer [J]. J Pathol, 2011,223(2) : 102-115.
  • 3Nikitina E G, Urazova L N, Stegny V N. mieroRNAs and human cancer[J]. Exp Oncol, 2012, 34(1) : 2 -8.
  • 4Mahgouh A, Steer C J. microRNAs in the evaluation and potential treatment of liver diseases[ J/OL]. J Clin Med, 2016, 5(5) : E52. doi: 10. 3390/jcm5050052.
  • 5Li Y, Zu L, Wang Y, et al. miR-132 inhibits lung cancer cell migration and invasion by targeting SOX4[ J]. J Thorae Dis, 2015, 7(9) : 1563 -1569.
  • 6Mahn R, Heukamp L C, Rogenhofer S, et al. Circulating microRNAs (miRNA) in serum of patients with prostate cancer [ J/OL ]. Urology, 2011, 77 (5): 1265. e9 - 16. doi: 10. 1016/ j. urology. 2011.01. 020.
  • 7Li C Y, Liang G Y," Yao W Z, et al. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression[J]. Clin Transl Oncol, 2016 May 12. [Epub ahead of print ].
  • 8Gulyaeva L F, Kushlinskiy N E. Regulatory mechanisms of microRNA expression[J/OL]. J Transl Med, 2016, 14 (1) : 143. doi: 10. 1186/s12967 - 016 - 0893 - x.
  • 9Yoshida K, Sugimoto N, lwahori S, et al. CDC6 interaction with ATR regulates activation of a replication checkpoint in higher enkaryotic cells[J]. J Cell Sci, 2010, 123(2) : 225 -235.
  • 10Xiong X D, Fang J H, Qiu F E, et al. A novel functional polymorphism in the Cdc6 promoter is associated with the risk for hepatocellular carcinoma[J]. Mut Res, 2008, 643(1): 70-74.

引证文献12

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部